British American Tobacco p.l.c. (BATS.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold BATS.L in your mock portfolio yet.
With a PE ratio around 10.3 and EPS of 4.07, the market is valuing British American Tobacco at a discount to many broader equity indices, consistent with a mature, regulated, cash‑generative business. These metrics suggest solid underlying earnings power but also reflect structural concerns around long‑term growth in combustible tobacco and regulatory risk. Profitability is likely still strong in absolute terms, but the valuation implies limited growth expectations and a focus on income rather than capital appreciation.
The stock trades at about $4.2K, modestly below its 200‑day moving average of $4.4K, indicating a mild downward bias or consolidation phase rather than a strong trend. An RSI of 40.78 is below the midline but not oversold, suggesting some recent weakness without capitulation. Overall, the technical picture points to a neutral to slightly cautious stance, with no clear bullish or bearish momentum signal.
Job openings at 279, up 9.4% month over month, point to ongoing operational activity and potential investment in capabilities, which is a mild positive signal. Social media metrics are mixed: flat Twitter/X followers, a slight decline on Facebook, and modest growth on YouTube, indicating stable but not rapidly expanding digital engagement. Overall, alternative data suggests a steady, mature franchise rather than a company experiencing either sharp deterioration or strong growth inflection.
Taken together, valuation, technicals, and alternative data point to a neutral outlook for British American Tobacco’s stock at current levels. The company appears fundamentally solid and cash‑generative, but the market’s low multiple, slightly weak technical posture, and largely stable alternative data suggest expectations for modest performance rather than a strong move in either direction. The risk‑reward profile looks more aligned with income and defensive positioning than with aggressive capital appreciation.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started